Sermorelin and ghrelin mimetics both stimulate endogenous growth hormone, but they operate through distinct molecular pathways. While Sermorelin acts via t
Read more Sermorelin vs. Ghrelin Mimetics: Comparative Receptor Pharmacology and Endocrine Pathways
An evidence-based examination of 5-Amino-1MQ, reviewing its preclinical safety profile, current FDA regulatory standing, mechanism as a small-molecule NNMT
Read more 5-Amino-1MQ: Safety Profile, Regulatory Status, and Clinical Evidence Gaps
An evidence-based review of TB-500, examining its regulatory status, preclinical safety data, structural divergence from full-length thymosin beta-4, and m
Read more TB-500: Regulatory Status, Safety Findings, and Research Limitations
Nicotinamide adenine dinucleotide (NAD+) is central to cellular bioenergetics and repair. While animal studies show dramatic longevity effects, human clini
Read more NAD+ in Human Clinical Trials: What the Current Evidence Shows
The Wolverine peptide stack combines synthetic peptides BPC-157 and TB-500 to target tissue repair. While preclinical studies show distinct actions on angi
Read more The Wolverine Peptide Stack: Cellular Mechanisms, Molecular Targets, and Research Gaps
PE-22-28 is a synthetic heptapeptide derived from the natural peptide spadin. Both target the TREK-1 potassium channel, but preclinical evidence shows PE-2
Read more PE-22-28 vs. Spadin: Comparative Evidence in TREK-1 Potassium Channel Research
Epitalon and Epithalamin are often conflated in longevity literature. This article reviews the critical scientific differences between synthetic Epitalon (
Tesamorelin, a synthetic growth hormone-releasing hormone analogue, has drawn significant scientific interest for its potential cognitive effects. Clinical
Read more Tesamorelin and Cognitive Function: What the Brain Research Shows
Cagrilintide is an investigational long-acting acylated peptide that functions as a dual amylin and calcitonin receptor agonist. By engaging calcitonin rec
Read more Cagrilintide: Dual Amylin and Calcitonin Receptor Agonism Explained
Eloralintide (LY3841136) is an investigational, long-acting selective amylin receptor agonist in clinical development for obesity management. Phase 2 human
Read more Eloralintide and Amylin Receptor Agonism: What the Clinical Research Shows